Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial

Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial

Abstract Background Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and considerable variability in the disease’s natural history. Besides lung transplantation (LTx), the only available treatments are anti-fibrosing drugs, which h...

Full description

Bibliographic Details
Main Authors: Gian Marco Manzetti, Karishma Hosein, Matthew J. Cecchini, Keith Kwan, Mohamed Abdelrazek, Maurizio Zompatori, Paola Rogliani, Marco Mura
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Pulmonary Medicine
Subjects:
Idiopathic pulmonary fibrosis
Prognosis
Survival
Mortality
Lung transplantation
Online Access:https://doi.org/10.1186/s12890-021-01753-7

Internet

https://doi.org/10.1186/s12890-021-01753-7

Similar Items